Researcher
Rüveyda Dok
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Aug 2011 → Today
Projects
1 - 6 of 6
- Real-time qPCR platform enhancing research activities within the Laboratory of Experimental Oncology and the Laboratory of Experimental RadiotherapyFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Unravelling and targeting hypoxia tolerance mechanisms in head and neck cancersFrom29 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Unraveling the radiobiology of protons and photons – using the model organism S. cerevisiaeFrom1 Sep 2018 → 28 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- DNA damage response as a mechanism for radioresistance in head and neck squamous cell carcinomaFrom1 Sep 2017 → 3 Sep 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Targeted inhibition of DNA repair as strategy to tackle radiation resistance in head and neck cancersFrom1 Jan 2017 → 31 Dec 2020Funding: Private funding of national origin - undefined
- Combining radiotherapy with DNA repair inhibitors as novel treatment strategy for head and neck cancersFrom18 Aug 2016 → 30 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 38
- Low-Level Laser Therapy Stimulates Proliferation in Head and Neck Squamous Cell Carcinoma Cells(2018)
Authors: Marieke Bamps, Rüveyda Dok, Sandra Nuyts
- Patient Selection in Human Papillomavirus Related Oropharyngeal Cancer: The Added Value of Prognostic Models in the New TNM 8th Edition Era(2018)
Authors: Sarah Deschuymer, Rüveyda Dok, Annouschka Laenen, Esther Hauben, Sandra Nuyts
- Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers(2017)
Authors: Mary Glorieux, Rüveyda Dok, Sandra Nuyts
Pages: 81662 - 81678 - Dual role for p16 in the metastasis process of HPV positive head and neck cancers(2017)
Authors: Rüveyda Dok, Mary Glorieux, Marieke Bamps, Sandra Nuyts
Pages: 113 - 113 - Prognostic Significance of Glutathione Peroxidase Levels (GPx1) in Head and Neck Cancers(2017)
Authors: Rüveyda Dok, Vincent Vander Poorten, Sandra Nuyts
- Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control(2017)
Authors: Daan Nevens, Jean-françois Daisne, Rüveyda Dok, Ann Belmans, Sandra Nuyts
Pages: 171 - 177 - Basal oxidative stress ratio of head and neck squamous cell carcinomas correlates with nodal metastatic spread in patients under therapy(2017)
Authors: Didier Dequanter, Rüveyda Dok, Sandra Nuyts
Pages: 259 - 263 - The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo(2016)
Authors: Annelies Gonnissen, Rüveyda Dok, Karin Haustermans
Pages: 84286 - 84298 - Differences in human papillomavirus-positive and -negative head and neck cancers in Belgium: an 8-year retrospective, comparative study(2016)
Authors: Koenraad Grisar, Rüveyda Dok, Joseph Schoenaers, Esther Hauben, Mark Jorissen, Sandra Nuyts, Constantinus Politis
Pages: 456 - 460 - Dependence of gold nanoparticle radiosensitization on functionalizing layer thickness(2016)
Authors: Cedric Spaas, Rüveyda Dok, Olivier Deschaume, Bert De Roo, Mattias Vervaele, Maria Seo, Carmen Bartic, Peter Hoet, Frank Van den Heuvel, Sandra Nuyts, et al.
Pages: 384 - 392